Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
04/30/2024 | Press release | Distributed by Public on 04/30/2024 07:32
Please select the service you want to use:
Smartlinks | SPARTA AG | Finance | Security Markets | Security Markets | Company News | Shareholders | Shareholder Meeting | Financial Services | Venture Capital | Investment Services | Securities Issuers | Venture Capital | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact